Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |